DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Netherlands
  • /
  • Healthcare
Author Program NEWCreate Narrative
PHIA logo

Koninklijke Philips N.V. Stock Price

ENXTAM:PHIA Community·€21.2b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 92 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

PHIA Share Price Performance

€21.72
-2.06 (-8.66%)
​
€27.00
Fair Value
€21.72
-2.06 (-8.66%)
19.5% undervalued intrinsic discount
€27.00
Fair Value
Price €21.72
AnalystConsensusTarget €27.00
AnalystLowTarget €22.00
AnalystHighTarget €33.56
Thu, 13 Aug 26
Fair Value€27.00
Share Pricen/a

PHIA Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value €27 19.5% undervalued intrinsic discount

AI-Enabled Healthcare Demand And Chronic Care Trends Will Drive Long-Term Upside

0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value €22 1.3% undervalued intrinsic discount

Trade Barriers And Regulatory Costs Will Cap Margins And Pressure Long Term Prospects

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value €33.56 35.3% undervalued intrinsic discount

AI Hospital Platforms And Productivity Programs Will Transform This Healthcare Leader

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
PHIA logo
Koninklijke Philips
1.3% undervalued intrinsic discount

Trade Barriers And Regulatory Costs Will Cap Margins And Pressure Long Term Prospects

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 11 Sep
Read Narrative
PHIA logo
Koninklijke Philips
35.3% undervalued intrinsic discount

AI Hospital Platforms And Productivity Programs Will Transform This Healthcare Leader

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 27 Aug
Read Narrative
PHIA logo
Koninklijke Philips
19.5% undervalued intrinsic discount

AI-Enabled Healthcare Demand And Chronic Care Trends Will Drive Long-Term Upside

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 13 Aug
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
PHIA logo

PHIA: AI Health Partnerships And Hospital Contracts Will Support Balanced Forward Outlook

Fair Value: €22 1.3% undervalued intrinsic discount
3 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
PHIA logo

PHIA: ARPA H Stroke Robotics Award Will Support Longer Term Earnings Profile

Fair Value: €33.56 35.3% undervalued intrinsic discount
4 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
PHIA logo

PHIA: Wearable Monitoring Partnerships And Exor Support Will Drive Future Upside Potential

Fair Value: €27 19.5% undervalued intrinsic discount
9 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Undervalued with solid track record and pays a dividend.

2 Risks
4 Rewards
View Full Analysis

Koninklijke Philips N.V. Key Details

€17.7b

Revenue

€9.6b

Cost of Revenue

€8.1b

Gross Profit

€7.0b

Other Expenses

€1.1b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Nov 03, 2026
1.14
45.94%
6.28%
56.7%
View Full Analysis

About PHIA

Founded
1891
Employees
63670
CEO
Roy Willem Jakobs
WebsiteView website
www.philips.com

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Recent PHIA News & Updates

User avatar
Narrative Update • Sep 11

PHIA: AI Health Partnerships And Hospital Contracts Will Support Balanced Forward Outlook

Analysts have lowered their price target on Koninklijke Philips to about €22 from roughly €23, citing updated assumptions for fair value, discount rate, revenue growth, margins, and future P/E multiples. What’s in the News for Koninklijke Philips Royal Philips introduced the eV14-2v transvaginal transducer for women’s health ultrasound, which is FDA 510(k) cleared and CE marked.

Recent updates

No updates

Koninklijke Philips N.V. Competitors

View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide